Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01148836 · ClinicalTrials.gov registry record · NA
Coenzyme Q-10 and Pulmonary Arterial Hypertension
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT01148836 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 18 participants.
The verdict
NCT01148836, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of Coenzyme Q-10, an antioxidant, in the treatment of pulmonary hypertension.
Interventions
- DIETARY_SUPPLEMENT Coenzyme Q-10 in Pulmonary Hypertension subjects
- DIETARY_SUPPLEMENT Coenzyme Q-10 in Normal Control subjects
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2010-01 |
| Est. Completion | 2014-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01148836
The ClinicalTrials.gov registry entry for NCT01148836 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Coenzyme Q-10 in Pulmonary Hypertension subjects is the first listed.
NCT01148836 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01148836 about?
NCT01148836 is a clinical study titled "Coenzyme Q-10 and Pulmonary Arterial Hypertension". The purpose of this study is to evaluate the effects of Coenzyme Q-10, an antioxidant, in the treatment of pulmonary hypertension.
What is the current status of trial NCT01148836?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2010-01. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01148836?
The interventions under investigation include: Coenzyme Q-10 in Pulmonary Hypertension subjects (DIETARY_SUPPLEMENT), Coenzyme Q-10 in Normal Control subjects (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01148836?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.